Display options
Share it on

Endocr Pathol. 1998;9(1):63-70. doi: 10.1007/BF02739953.

Immunodetection of Insulin-Like Growth Factor I (IGF-l) in Normal and Pathological Adrenocortical Tissue.

Endocrine pathology

Samir Faical, Rui M. B. Maciel, Vania Nose-Alberti, Marivania C. Santos, Claudio E. Kater

Affiliations

  1. MD, PhD.

PMID: 12114663 DOI: 10.1007/BF02739953

Abstract

IGF-I is one of the peptides that participates in normal adrenocortical cell growth and, possibly, in the genesis and/or maintenance of tumors and hyperplasias of the adrenal cortex. An immunohistochemical technique was used for the analysis of IGF-l expression in eight control and four hyperplastic adrenals, 11 adrenal cortical adenomas, and 18 adrenal cortical carcinomas. A large number of IGF-I positive cells with granular cytoplasmic (GC) staining pattern was found in the reticularis layer of control adrenal tissues. Fifty percent of the hyperplasias had the GC pattern and the other 50% a mixed pattern; in 64% of the tumors, the adenomas showed a LM (linear membrane) pattern, while adenocarcinomas usually showed a GC pattern (94%). Approximately 75% of the hyperplasias had between 10 and 50% of IGF-l positive cells, while adenomas and carcinomas had over 50% of IGF-I positive cells in 64% and 83% of the samples, respectively. The size of the tumors with 50% positive cells, compared with those with less than 50%, was, on average, greater, but no statistical differences between cell positivity and corresponding clinical syndrome were observed. Thus, detection of IGF-l in control and pathological adrenal tissue suggests participation of this growth factor in cell function and/or growth and proliferation.

References

  1. Annu Rev Physiol. 1985;47:443-67 - PubMed
  2. J Biol Chem. 1989 Apr 25;264(12):6858-62 - PubMed
  3. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2389-92 - PubMed
  4. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2216-20 - PubMed
  5. Cell Differ. 1986 Jul;19(1):1-17 - PubMed
  6. J Clin Invest. 1981 Nov;68(5):1321-30 - PubMed
  7. J Clin Invest. 1988 Jul;82(1):354-9 - PubMed
  8. J Clin Endocrinol Metab. 1994 Mar;78(3):731-5 - PubMed
  9. Acta Paediatr Scand Suppl. 1988;347:104-9 - PubMed
  10. J Steroid Biochem. 1990 Aug 28;36(6):583-8 - PubMed
  11. J Clin Endocrinol Metab. 1985 Oct;61(4):639-43 - PubMed
  12. Endocr Pathol. 1995 Autumn;6(3):207-215 - PubMed
  13. J Mol Endocrinol. 1989 Nov;3(3):183-90 - PubMed
  14. FEBS Lett. 1993 Aug 9;328(1-2):94-8 - PubMed
  15. Cancer Res. 1990 Jan 1;50(1):103-7 - PubMed
  16. J Cell Biol. 1988 Aug;107(2):811-9 - PubMed
  17. Proc Natl Acad Sci U S A. 1986 Feb;83(3):664-8 - PubMed
  18. J Histochem Cytochem. 1980 Aug;28(8):824-35 - PubMed
  19. Biochem Biophys Res Commun. 1989 Nov 30;165(1):204-11 - PubMed
  20. Endocrinol Jpn. 1987 Aug;34(4):611-4 - PubMed
  21. Am J Clin Pathol. 1992 Jan;97(1):73-83 - PubMed
  22. J Histochem Cytochem. 1970 May;18(5):315-33 - PubMed
  23. J Clin Endocrinol Metab. 1982 May;54(5):1084-6 - PubMed
  24. Am J Pathol. 1991 Jan;138(1):83-91 - PubMed
  25. Recent Prog Horm Res. 1981;37:41-103 - PubMed
  26. J Clin Invest. 1988 Nov;82(5):1546-53 - PubMed
  27. Endocrinology. 1979 Mar;104(3):588-95 - PubMed
  28. Life Sci. 1989;45(5):383-9 - PubMed
  29. J Clin Endocrinol Metab. 1993 Sep;77(3):852-8 - PubMed
  30. J Clin Endocrinol Metab. 1988 Jun;66(6):1227-32 - PubMed
  31. Endocrinology. 1988 Jun;122(6):2518-26 - PubMed

Publication Types